Current Location:home > Browse

Submitted Date

1. chinaXiv:202003.00008 [pdf]

Germline Polymorphisms and Length of Survival of Nasopharyngeal Carcinoma: An Exome-Wide Association Study in Multiple Cohorts

Yun-Miao Guo; Jie-Rong Chen; Yan-Chun Feng; Chua, Melvin L. K. ; Zeng, Yanni ; Edwin Pun Hui; Allen K. C. Chan; Lin-Quan Tang; Lin Wang; Qian Cui; Hui-Qiong Han; Chun-Ling Luo; Guo-Wang Lin; Yan Liang; Yang Liu; Zhong-Lian He; Yu-Xiang Liu; Pan-Pan Wei; Chu-Jun Liu; Wan Peng
Subjects: Medicine, Pharmacy >> Clinical Medicine

Germline polymorphisms have been linked with differential survival outcomes in cancers but have not been well studied in nasopharyngeal carcinoma (NPC). Here, two-phase association study is conducted to discover germline polymorphisms that are associated with the prognosis of NPC. The discovery phase includes two consecutive hospital cohorts of patients with NPC from Southern China. Exome-wide genotypes at 246,173 single nucleotide polymorphisms (SNPs) are determined, followed by survival analysis for each SNP under Cox proportional hazards regression model. Candidate SNP is replicated in another two independent cohorts from Southern China and Singapore. Meta-analysis of all samples (n = 5,553) confirm that the presence of rs1131636-T, located in the 3′-UTR of RPA1, confers an inferior overall survival (HR = 1.33, 95% CI = 1.20-1.47, P = 6.31 × 10-8). Bioinformatics and biological assays show that rs1131636 has regulatory effects on upstream RPA1. Functional studies further demonstrate that RPA1 promoted the growth, invasion, migration, and radioresistance of NPC cells. Additionally, miR-1253 has been identified as a suppressor for RPA1 expression, likely through regulation of its binding affinity to rs1131636 locus. Collectively, these findings provide a promising biomarker aiding in stratifying patients with poor survival, as well as a potential drug target for NPC.

submitted time 2020-03-06 Hits17722Downloads1006 Comment 0

2. chinaXiv:201901.00071 [pdf]

Clinical study on Transcranial magnetoelectric encephalopathy treatment instrument treatmenting parkinson’s disease

Qiang Tang; Wei Zou; Zuodong Sun; Kang Li; Wuyi Sun; Wenhua Wang; Yanli Xing; Xueping Yu; Jing Bai; Xiuying Teng; Yan Hou
Subjects: Medicine, Pharmacy >> Clinical Medicine
Subjects: Physics >> Electromagnetism, Optics, Acoustics, Heat Transfer, Classical Mechanics, and Fluid Dynamics

[Objective] Evaluate on the treatment efficacy and safety for transcranial magnetoelectric encephalopathy treatment instrument (brand name: AOBO Parkinson’s Treatment Instrument) treatmenting parkinson's disease. [Methods] Use methods of double center,randomized, double blind, self crossover, 22 Parkinson’s patients who met the inclusion criteria were randomly divided into A group and B group, then were carried on the curative effect analysis, and were observed therapeutic effect. [Results] The treatment group of 22 cases, basically cured in 0 cases, markedly effective in 9 cases, effective in 8 cases, ineffective in 5 cases. The total efficiency rate and total effective rate were 40.91% (9/22) or 77.27% (17/22) respectively. The control group of 22 cases, basically cured in 0 cases, markedly effective in 2 cases, effective in 3 cases, ineffective in 17 cases. The total efficiency rate and total effective rate were 9.09% (2/22) or 22.73% (5/22) respectively, the total effective rate and total effective rate in the treatment group were higher than those in the control group, the difference was statistically significant (P<0.05). Among them, the main symptoms of resting tremor, rigidity, bradykinesia, evaluation, the treatment group has significant difference (P<0.01); There was no significant difference in the control group (p>0.05); There was significant difference between the treatment group and the control group (p<0.05). [Conclusions] Transcranial magnetoelectric stimulation can significantly improve resting tremor, muscle rigidity, bradykinesia in patients with Parkinson’s disease and other symptoms, and the use of safety. "

submitted time 2019-01-15 Hits20166Downloads810 Comment 0

3. chinaXiv:201901.00070 [pdf]

重复经颅磁电刺激对海人酸致痫鼠的疗效研究

张旺; 王孝义; 郭洪渠; 宋媛媛; 王爱丽; 孙作东; 沈红
Subjects: Medicine, Pharmacy >> Clinical Medicine
Subjects: Physics >> Electromagnetism, Optics, Acoustics, Heat Transfer, Classical Mechanics, and Fluid Dynamics

目的 探讨经颅磁电刺激(TMES)疗法对海仁酸(KA)致颞叶癫痫鼠的疗效。 方法 62只大鼠按照随机数字表法分为预处理组(共32只)和治疗组(共30只),预处理组再分为4个小组,分别给予治疗仪最大电流强度(MCI) 0%,25%,50%,75%的电流刺激,确定本实验条件下的最佳刺激参数。治疗组再分为3个小组,每组10只。2组(癫痫刺激组、癫痫非刺激组)为符合纳入标准的癫痫模型大鼠,刺激组刺激参数为预处理组确定出的最佳刺激参数;非刺激组大鼠刺激前后处理与刺激组相同,但治疗仪无有效的能量输出。第3组对照组为未造模对照大鼠。3组大鼠均给予每天1次,40 min/次,共14 d的刺激。记录并比较3组大鼠行为学、电生理学及组织学变化,以评估TMES疗法对癫痫大鼠的疗效。 结果 50%MCI为最佳刺激强度。癫痫刺激组大鼠癫痫波出现的频率明显低于癫痫非刺激组大鼠[(30.210 ±4.580)次/min vs. (31.380 ± 4.247)次/min],差异有统计学意义(t=3.235,P=0.001)。Timm染色结果提示3组大鼠染色评分差异有统计学意义(F=17.429, P=0.000),癫痫刺激组大鼠海马齿状回的内分子层Timm染色评分较癫痫非刺激组明显减轻,差异有统计学意义(P<0.05)。结论 TMES疗法可通过改善癫痫大鼠海马齿状回内分子层组织学变化程度来影响齿状回神经元环路的形成,进而降低癫痫脑电波的发作频率。

submitted time 2019-01-02 Hits11874Downloads870 Comment 0

  [1 Pages/ 3 Totals]